• 1
    Kurland LT, Hauser WA, Ferguson RH, Holley KE: Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc 44: 649663, 1969
  • 2
    Medsger TA Jr, Masi AT: Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 74: 714721, 1971
  • 3
    Medsger TA Jr, Masi AT: The epidemiology of systemic sclerosis (scleroderma) among male US veterans. J Chronic Dis 31: 7385, 1978
  • 4
    Eason RJ, Tan PL, Gow PJ: Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features. Aust NZ J Med 11: 657662, 1981
  • 5
    Giordano M, Valentini G, Ara M, Tirri G, Capelli L, Vatti M: Epidemiology of progressive systemic sclerosis in Italy, Systemic Sclerosis (Scleroderma). Edited by CMBlack, ARMyers. New York, Gower, 1985
  • 6
    Shinkai H: Epidemiology of progressive systemic sclerosis in Japan, Systemic Sclerosis (Scleroderma). Edited by CMBlack, ARMyers. New York, Gower, 1985
  • 7
    Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT: Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 60: 105113, 1985
  • 8
    Steen V, Conte C, Santoro D, Casterline GLZ, Oddis CV, Medsger TA Jr: Twenty-year incidence survey of systemic sclerosis (abstract). Arthritis Rheum 31(suppl 4): S57, 1988
  • 9
    Masi AT: Potential uses and limitations of hospital data in epidemiologic research. Am J Public Health 55: 658667, 1965
  • 10
    Masi AT, D'Angelo WA: Epidemiology of fatal systemic sclerosis (diffuse scleroderma). Ann Intern Med 66: 870883, 1967
  • 11
    De Takats G, Fowler EF: Raynaud's phenomenon. JAMA 179: 18, 1962
  • 12
    Velayos EE, Robinson H, Porciuncula FU, Masi AT: Clinical correlation analysis of 137 patients with Raynaud's phenomenon. Am J Med Sci 262: 347356, 1971
  • 13
    Vayssairat M, Fiessinger JN, Housset E: Phénomène de Raynaud: étude prospective de 100 cas. Nouv Presse Med 8: 21772180, 1979
  • 14
    Porter JM, Rivers SP, Anderson CJ, Baur GM: Evaluation and management of patients with Raynaud's syndrome. Am J Surg 142: 183189, 1981
  • 15
    Lewis T, Pickering GW: Observations upon maladies in which the blood supply to digits ceases intermittently or permanently, and upon bilateral gangrene of digits: observations relevant to so-called “Raynaud's disease”. Clin Sci 1: 327366, 1933–1934
  • 16
    Fessel WJ: Rheumatology for Clinicians. New York, Stratton, 1975
  • 17
    Olsen N, Nielsen SL: Prevalence of primary Raynaud phenomena in young females. Scand J Clin Lab Invest 37: 761764, 1978
  • 18
    Heslop J, Coggon D, Acheson ED: The prevalence of intermittent digital ischaemia (Raynaud's phenomenon) in a general practice. J R Coll Gen Pract 33: 8589, 1983
  • 19
    Leppert J, Aberg H, Ringqvist I, Sorensson S: Raynaud's phenomenon in a female population: prevalence and association with other conditions. Angiology 38: 871877, 1987
  • 20
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581590, 1980
  • 21
    Maricq HR, Weinrich MC, Keil JE, LeRoy EC: Prevalence of Raynaud phenomenon in the general population: a preliminary study by questionnaire. J Chronic Dis 39: 423427, 1986
  • 22
    Lam JJ, Weinrich MC: A new sampling plan for the Carolina Health Survey, Proceedings of the American Statistical Association, Section on Survey Research Methods. 1981
  • 23
    Weinrich MC, Maricq HR, Keil JE, McGregor AR, Diat F: Prevalence of Raynaud phenomenon in the adult population of South Carolina. Submitted for publication
  • 24
    Maricq HR: The microcirculation in scleroderma and allied diseases. Advances in Microcirculation. Edited by EDavis. Basel, Karger, 1982
  • 25
    Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC: Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1: 195205, 1983
  • 26
    Maricq HR, Weinrich MC: Diagnosis of Raynaud's phenomenon assisted by color charts. J Rheumatol 15: 454459, 1988
  • 27
    Maricq HR: Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24: 11591165, 1981
  • 28
    Maricq HR: Nailfold capillary photography, Progress in Applied Microcirculation: Techniques in Clinical Capillary Microscopy. Vol. 11. Edited by KMessmer, FHammersen. Basel, Karger, 1986
  • 29
    Maricq HR: Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. Microvasc Res 32: 271276, 1986
  • 30
    Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9: 175176, 1958
  • 31
    Arnett FC, Edworthy S, Block DA, McShane DJ, Fries JF, and the ARA Rheumatoid Arthritis Criteria Subcommittee: The 1987 revised ARA criteria for rheumatoid arthritis (abstract). Arthritis Rheum 30(suppl 4): S17, 1987
  • 32
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 12711277, 1982
  • 33
    Bohan A, Peter JB, Bowman RL, Pearson CM: A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 56: 255286, 1977
  • 34
    Statistical Abstract of the United States: 1987. 108th edition. Washington, DC, US Bureau of the Census, 1987
  • 35
    Sheldon WB, Lurie DP, Maricq HR, Kahaleh MB, DeLustro FA, Gibofsky A, LeRoy EC: Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindred. Arthritis Rheum 24: 668676, 1981
  • 36
    McGregor AR, Watson A, Yunis E, Pandey JP, Takehara K, Tidwell JT, Ruggieri A, Silver RM, LeRoy EC, Maricq HR: Familial clustering of scleroderma spectrum disease. Am J Med 84: 10231032, 1988
  • 37
    Camus J-P, Emerit I, Reinert P, Guillien P, Crouzet J, Fourot J: Sclérodermie familiale avec syndrome de Sjögren et anomalies lymphocytaires et chromosomiques. Ann Med Interne (Paris) 121: 149161, 1970
  • 38
    Greger RE: Familial progressive systemic scleroderma. Arch Dermatol 111: 8185, 1975